Emory Drug Deal Turns Heads

Jumbo $525 Million Royalty Rights Payment Captures Wall Street’s Attention

New York, NY – January 16, 2006 – Wall Street is rubbing its hands in anticipation of more to come after Emory University’s groundbreaking deal to sell the royalty rights for an HIV drug developed by school researchers. Gilead Sciences and Royalty Pharma paid a whopping $525 million for the rights, the largest lump-sum royalty payment to a US university to date.

Source: Original Article